Auditory and Vestibular Function in Patients Treated with Oxaliplatin-Containing Chemotherapy

Purpose: This clinical trial is evaluating hearing loss and dizziness in patients receiving oxaliplatin (a chemotherapy medication) for solid tumors.

Participants: This study is currently recruiting 60 study subjects aged 18 years and older, with certain disease and patient characteristics (visit NCT00305799 for further information).

Study Chair: Panos Savvides, MD, Case Comprehensive Cancer Center, Cleveland, Ohio

Contact: If you are interested in participating, please call (800) 641-2422